ICD10 code of Hallucinogen Persistent Perception Disorder and ICD9 code

Hallucinogen Persistent Perception Disorder (HPPD) does not have a specific, unique code in the ICD-9-CM classification system, but it is classified under ICD-10-CM code F16.983 (Hallucinogen-related disorder with hallucinogen persisting perception disorder). Recognizing this specific diagnostic code is an essential step for patients seeking medical documentation for insurance purposes or clinical support.

What is the clinical definition of Hallucinogen Persistent Perception Disorder?

Hallucinogen Persistent Perception Disorder is a condition characterized by the re-experiencing of visual disturbances that were originally associated with hallucinogen use, long after the substance has cleared from the body. Unlike typical "flashbacks," the symptoms of Hallucinogen Persistent Perception Disorder are often constant, distressing, and pervasive, significantly impacting a patient's quality of life. Currently, 260 members of the DiseaseMaps.org community have identified themselves as living with this condition, sharing their unique journeys and symptom management strategies.

What are the primary visual symptoms of Hallucinogen Persistent Perception Disorder?

The hallmark of Hallucinogen Persistent Perception Disorder is persistent visual distortion. Patients frequently report that these symptoms vary in intensity based on stress, fatigue, or ambient lighting. Common clinical manifestations include:

• Visual Snow: A persistent grainy or static-like overlay across the entire field of vision.


• After-images (Palinopsia): Seeing lingering trails or "ghost" images when an object moves.


• Halos: Glowing rings or light flares around light sources.


• Macro/Micropsia: Distortions in perceived depth, size, or dimensions of objects.


• Enhanced Color Perception: Intense or unnatural shifts in color saturation.

How is Hallucinogen Persistent Perception Disorder managed?

Management of Hallucinogen Persistent Perception Disorder requires a cautious, individualized approach. While there is no FDA-approved cure, clinicians may trial medications such as anticonvulsants, benzodiazepines, or specific SSRIs. However, it is critical to note that some treatments, including certain antipsychotics like risperidone, have been reported to exacerbate symptoms in clinical trials. Because Hallucinogen Persistent Perception Disorder is complex, patients should maintain a detailed symptom journal to track how specific interventions affect their visual perception.

Next steps

• Consult with a neurologist or a psychiatrist specializing in sensory processing disorders.


• Join the Hallucinogen Persistent Perception Disorder community on DiseaseMaps.org to connect with others who understand the condition.


• Document all visual symptoms and medication side effects to assist your specialist in creating a safe treatment plan.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• ICD-10-CM Browser (National Center for Health Statistics)


• PubMed Central: "Clinical overview of Hallucinogen Persisting Perception Disorder"


• Orphanet: Rare Disease Database